Molecular Partners AG
MP0712
small cell lung cancer
Resolved
187days ago
Phase 1 readout · ~ Jan 1, 2026 estimated
What's at stake
Phase 1 trial results for MP0712 in small cell lung cancer are due ~ Jan 1, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 15h ago
“initiation of a Phase 1/2a study.”